Red light therapy for wound healing targets the biology that determines whether a wound closes quickly or becomes a chronic, costly medical problem. For the roughly 8.2 million Medicare beneficiaries living with at least one wound or wound-related infection, and the millions more managing wounds outside that system, the difference between a wound that heals and one that doesn't often comes down to what is happening at the cellular level.
Chronic wounds are also widespread and expensive: a 2018 cost analysis in Value in Health put the burden on the U.S. Medicare system at between $28.1 billion and $96.8 billion a year, and a 2020 NHS cohort study estimated that wound care cost the UK's National Health Service £8.3 billion in a single year. Behind those numbers is a medical reality that conventional wound care, while essential, often cannot resolve. When a wound stalls partway through its normal healing phases, no amount of debridement, dressings, or antibiotics can replace the cellular activity that has stopped.
Red and near-infrared light therapy, clinically known as photobiomodulation, works at precisely that level. It delivers specific wavelengths of light that penetrate tissue and are absorbed by structures inside the cell, triggering measurable increases in energy production, blood vessel formation, collagen synthesis, and inflammation resolution. The first meta-analysis of low-level laser therapy in human skin wounds (Taha et al., 2024) found that treated wounds healed significantly faster and more completely than untreated controls across 18 randomized controlled trials. That finding sits on top of a research base spanning diabetic foot ulcers, surgical wounds, burns, pressure injuries, and venous ulcers, supported by multiple independent meta-analyses and systematic reviews.
Key Takeaways
- A 2024 meta-analysis of 18 randomized controlled trials (Taha et al.) found that low-level laser therapy produced significantly greater wound size reduction and significantly higher complete healing rates compared to standard care alone, with treated wounds also reporting lower pain scores.
- Red light therapy works through eight distinct biological mechanisms that operate across all three phases of wound healing: the inflammatory phase, the proliferative phase, and the remodeling phase. These mechanisms include restoring cellular energy, reducing inflammation, reprogramming immune cells from tissue destruction to tissue repair, stimulating cell growth and migration, promoting new blood vessel formation, enhancing collagen production, managing oxidative stress, and reducing wound pain.
- The strongest clinical evidence is in diabetic foot ulcers, where three independent meta-analyses (Chen et al., 2025; Huang et al., 2021; Miranda et al., 2025) and a network meta-analysis comparing 12 different interventions (Hu et al., 2025) have consistently found significant benefits from photobiomodulation as an adjunctive therapy. In one head-to-head randomized trial (Wadee et al., 2021), red light therapy matched hyperbaric oxygen therapy for diabetic foot ulcer healing and outperformed it on early wound volume reduction.
What Is Wound Healing, and Why Do Some Wounds Fail to Heal?
A wound is any break in the integrity of the skin or underlying tissue. Wound healing is a tightly coordinated biological process that unfolds in three overlapping phases. In the inflammatory phase, the body sends immune cells to the wound site to clear debris and fight infection. In the proliferative phase, new blood vessels form, specialized cells called fibroblasts build a scaffold of collagen, and new skin cells migrate across the wound surface. In the remodeling phase, the initial repair tissue is restructured and strengthened over weeks to months.
When this process works, even significant wounds close within a predictable timeframe. When it doesn't, the wound becomes chronic, a clinical designation that typically applies to any wound that has not progressed through the expected healing phases within four to six weeks.
Chronic wounds are not a problem in otherwise healthy people. They occur overwhelmingly in patients who carry one or more conditions that disrupt the cellular machinery of healing. Diabetes is the most significant: impaired blood sugar control damages blood vessels, reduces oxygen delivery to tissue, weakens the immune response, and slows the activity of the fibroblasts responsible for building new tissue. Peripheral vascular disease restricts blood flow to the extremities. Age-related cellular decline means the fibroblasts and immune cells themselves are less active and less responsive. Obesity, malnutrition, immunosuppression, and sustained mechanical pressure each contribute independently.
What these risk factors share is that they all act at the cellular level. They leave less energy for repair, slow the formation of new blood vessels, and keep inflammation smoldering when it should have resolved. They also stall collagen production, the structural work that actually closes a wound. Conventional wound care manages the wound from the outside, with dressings, debridement, pressure offloading, infection control, and blood sugar control. That care is essential, and it remains the foundation. Red light therapy works from the inside, on the cellular processes these conditions have impaired.
That same distinction, between managing the wound from outside and reaching the cells within, is how the article's medical reviewer weighs the therapy from the bedside:
Most of the chronic wounds I see aren't failing because the patient is doing something wrong. They're failing because the cells at the wound site don't have what they need to do their job. The blood supply is poor, the inflammation won't settle, the fibroblasts are sluggish. We manage the wound as well as we can from the outside, with dressings and debridement, but you can't make tired cells work harder with a bandage. What draws me to the photobiomodulation data is that it targets that exact level. For diabetic foot ulcers especially, where the meta-analysis evidence has gotten strong, it gives us something that works on the biology standard wound care just can't reach.— Dr. William Carter, MD
How Red Light Therapy Accelerates Wound Healing: Eight Biological Mechanisms
Red and near-infrared light in the 630–850 nm wavelength range penetrates the skin and is absorbed by a specific protein inside the mitochondria called cytochrome c oxidase. This absorption event triggers a chain of biological responses that operate across every phase of wound healing. A systematic review of 27 experimental studies (Da Rocha et al., 2024) confirmed that LED-based photobiomodulation stimulates cell proliferation, cell migration, new blood vessel formation, collagen deposition, and inflammatory modulation across all phases of healing.
For wounds, eight distinct mechanisms are relevant. Each plays a different role depending on the type of wound and the phase of healing it has stalled in.
Restoring Cellular Energy Production
Every step of wound healing runs on energy. Immune cells need it to clear the wound bed, fibroblasts to produce collagen, keratinocytes to crawl across the wound surface, and the cells that line blood vessels to build new ones. When the cells at a wound site run low on energy, as they do in diabetic tissue, aged tissue, or tissue with poor blood supply, healing slows or stops.
Red and near-infrared light is absorbed by cytochrome c oxidase, an energy-making protein in the mitochondria, and the cell responds by making more adenosine triphosphate (ATP), the molecule it burns as fuel. The effect has been measured in living human tissue. Using a specialized scan, Fear et al. (2023) tracked ATP in the brains of older adults before and after a session of transcranial photobiomodulation and recorded a significant jump after a single treatment. The mitochondrial basis goes back further: Wong-Riley et al. (2005) showed that 670 nm red light revived neurons that had been poisoned with metabolic toxins, restoring their energy output and function.
For wound healing, this energy boost is the upstream event that enables everything else. A cell that cannot produce enough energy cannot divide, migrate, build collagen, or resolve inflammation effectively. Restoring energy production restores the cell's capacity to take part in every phase of repair.
Reducing Inflammation and Shifting the Immune Response
Inflammation is a necessary part of early wound healing. It clears damaged tissue and fights infection. The problem is when it doesn't resolve. In chronic wounds, the inflammatory phase persists for weeks or months, with elevated levels of pro-inflammatory signaling molecules that actively prevent the wound from transitioning to the proliferative phase. This sustained inflammation degrades the collagen that fibroblasts are trying to build, damages newly forming blood vessels, and creates a destructive cycle that keeps the wound open.
Red light therapy nudges the inflammatory response toward resolution. In a randomized, placebo-controlled trial, Tomazoni et al. (2020) found that a single session of photobiomodulation cut a key pain-sustaining inflammatory signal (prostaglandin E2) in patients with chronic low back pain, compared with placebo. Lim et al. (2013) traced part of how this works at the cellular level: 635 nm red light switched off a master inflammatory signal in human gum cells, acting through a stress-response protein that behaves like a brake on runaway inflammation.
The effect goes beyond simply switching inflammation off. Photobiomodulation raises anti-inflammatory signals while lowering pro-inflammatory ones, which actively rebalances the immune environment. A 2025 review by Al Balah et al. confirmed this immune-regulating pattern across multiple conditions: the therapy shifts the inflammatory profile rather than just dampening it. For a wound, that is exactly the goal, enough inflammation to fight infection and clear debris, but not so much that it blocks the move into rebuilding.
For more on how red light therapy modulates inflammation at the cellular level, see our dedicated article on red light therapy for inflammation.
Reprogramming Immune Cells from Destruction to Repair
Beyond reducing inflammatory signals, red light therapy physically changes how immune cells behave at the wound site. The most critical example for wound healing is macrophage polarization. Macrophages are immune cells that exist on a spectrum between two functional states: M1 (pro-inflammatory, tissue-destroying) and M2 (anti-inflammatory, tissue-repairing). In chronic wounds, macrophages get stuck in the M1 state, perpetuating damage even after the original trigger is gone. The transition from M1 to M2 is one of the decisive events that determines whether a wound moves from the inflammatory phase to the proliferative phase.
A 2026 study in Advanced Science (Shi et al.) showed how different wavelengths control this switch. In both cell culture and live wounds, 850 nm near-infrared light changed how macrophages burned fuel and reshaped their mitochondria, pushing them toward the repairing M2 state and speeding tissue repair. The team confirmed cause and effect: when they blocked the fuel-burning changes the light set off, the shift reversed. A review by Ferreira et al. (2025) of 19 studies found the same pattern across the 630–890 nm range, with light reliably promoting the M2 state and suppressing M1 through several known signaling pathways.
In a diabetic wound model, Moradi et al. (2025) found that photobiomodulation cut M1 counts and raised M2 counts at both day 4 (the inflammatory phase) and day 8 (the proliferative phase). The treated wounds also showed higher levels of the growth factors that drive blood vessel formation and tissue rebuilding.
For chronic wounds, where the inflammatory phase has stalled, this mechanism addresses one of the root causes directly: it doesn't just reduce inflammatory signals, it converts the immune cells themselves from a tissue-destroying program to a tissue-building one.
Stimulating Cell Proliferation and Migration
A wound cannot close unless the cells responsible for repair actively multiply and move into the wound bed. Fibroblasts must proliferate and migrate to build the structural scaffold. Keratinocytes must multiply and crawl across the wound surface to restore the skin barrier. In chronic wounds, particularly in diabetic patients and older adults, these cellular activities are impaired.
Red light therapy stimulates both multiplication and migration in the cells that matter most for repair. A systematic review by Da Rocha et al. (2024), covering 27 experimental studies, found that LED photobiomodulation boosted both across wound models, with red wavelengths especially effective. In the lab, Mathioudaki et al. (2023) scratched a gap across a dish of keratinocytes, a standard stand-in for a wound, and found that 661 nm red laser light sped the cells' migration to close it.
Choi et al. (2025) added a useful detail in a diabetic wound model: pulsed photobiomodulation didn't just make cells move faster, it improved the grip-and-pull machinery cells use to haul themselves across the wound bed. That matters in diabetic tissue, where poor cell adhesion is a specific barrier to healing.
Promoting New Blood Vessel Growth and Improving Microcirculation
Oxygen and nutrients reach healing tissue through blood vessels. In wounds with poor underlying circulation, whether from diabetes, peripheral vascular disease, or the local tissue damage of the wound itself, the lack of adequate blood supply is a primary reason healing stalls. New blood vessel formation (angiogenesis) and improved flow through existing small vessels (microcirculation) are both required.
Red light therapy drives both. The quick effect runs through nitric oxide. When red and near-infrared light strikes certain mitochondrial enzymes, it frees nitric oxide molecules, which slip into the surrounding tissue and relax and widen the blood vessels. Keszler et al. (2018) showed this wavelength-dependent release of nitric oxide in a biochemistry study. Gavish et al. (2020) caught the downstream result in a randomized controlled trial: near-infrared light raised microcirculatory blood flow by 27%, and the effect kept climbing to 54% over the twenty minutes after treatment.
Beyond that immediate widening, red light therapy stimulates the formation of entirely new blood vessels. In a diabetic mouse model with limb ischemia (restricted blood flow), Huang et al. (2021) showed that photobiomodulation promoted angiogenesis, the growth of new vessels into oxygen-deprived tissue.
Cury et al. (2013) found a key pathway: in oxygen-starved tissue, low-level laser therapy raised the main blood-vessel growth factor (VEGF) and the body's master signal for responding to low oxygen, and new vessels followed. Torkaman et al. (2024) took this to patients. In a randomized controlled trial in diabetic foot ulcers, photobiomodulation raised levels of that same growth factor and its receptor in the wound itself, direct human evidence of the vessel-growing effect at work.
For chronic wounds in patients with poor circulation, this mechanism tackles one of the most basic barriers to healing.
Enhancing Collagen Synthesis and Tissue Remodeling
Collagen is the structural protein that forms the framework of healing tissue. Without adequate collagen production, a wound may partially close but produce fragile, disorganized tissue that breaks down easily. The transition from initial wound repair to durable, remodeled tissue depends on the balance between collagen production, organized deposition, and the controlled breakdown of damaged or disorganized matrix.
Red light therapy works on all three sides of this balance. Ayuk et al. (2018) found that photobiomodulation lowered the enzymes that break tissue down (matrix metalloproteinases) while raising the proteins that protect it, in stressed skin cells. Genah et al. (2021) saw the same shift in fibroblasts under inflammatory stress, the conditions of a chronic wound. In a chronic wound, those breakdown enzymes run wild and destroy collagen faster than fibroblasts can build it, so the wound stays open.
A narrative review by Shaikh-Kader and Houreld (2022) looked across connective-tissue cells in bone, cartilage, and tendon, and found that at the right wavelengths and doses, photobiomodulation stimulates repair-cell activity, new collagen, and structural rebuilding in all three. Cavalcanti et al. (2024) added the fibroblast-specific picture, confirming that photobiomodulation drives fibroblast activity and the building of the surrounding tissue scaffold across a range of settings.
For wounds moving from the proliferative phase into remodeling, this mechanism supports repair tissue that is stronger and better organized, the kind that holds up over time.
Managing Oxidative Stress
Chronic wounds sit in a state of oxidative stress: too many reactive oxygen molecules, which damage cells, degrade collagen, and impair every cell type involved in healing. It is worst in diabetic wounds, where high blood sugar keeps the oxidative damage coming.
Red light therapy's effect here depends on context, much as it does with inflammation. In cells already under oxidative stress, photobiomodulation lowers the harmful reactive oxygen molecules and shores up antioxidant defenses. Tomazoni et al. (2019) showed this in a randomized controlled trial with elite soccer players: light before exercise raised antioxidant enzyme activity and lowered markers of oxidative damage against placebo. A systematic review by Dos Santos et al. (2017) found the same combination, less oxidative damage and more antioxidant enzymes, across multiple animal models of tissue injury.
In healthy cells, the same light creates a brief, small burst of reactive oxygen molecules that works as a signal, prompting the cell's antioxidant defenses to ramp up. It is the same principle as exercise: a small, controlled stress that triggers a larger protective response. For a wound, the net result is a move toward healthier oxidative balance in tissue that had been stuck in damage.
Reducing Pain at the Wound Site
Wound pain is more than a quality-of-life issue. It drives stress hormone production, impairs sleep, and reduces adherence to wound care protocols, all of which independently slow healing. Many patients with chronic wounds, particularly diabetic foot ulcers and venous leg ulcers, experience significant daily pain.
The Taha et al. (2024) meta-analysis found that low-level laser therapy significantly lowered pain scores in wound patients versus controls. Two things drive that relief. One is the anti-inflammatory effect, which cuts the chemical irritation behind wound pain. The other is direct: red light raises the firing threshold of pain-sensing nerve fibers and slows the pain signal itself, working through a route that does not depend on anti-inflammatory drugs.
For a comprehensive review of how red light therapy modulates pain, see our dedicated article on red light therapy for neuropathy. For patients recovering from surgical wounds, see our article on red light therapy after surgery.
Does Red Light Therapy Work for Wound Healing? What Clinical Trials Show
The mechanistic evidence establishes how red light therapy works in wounds. The clinical trial evidence, now spanning multiple meta-analyses across different wound types, establishes whether it actually accelerates healing in real patients. The consistent answer across that evidence is yes, with the effect size varying by wound type and treatment parameters.
Skin Wounds Overall
The Taha et al. (2024) meta-analysis is the anchor finding. It pooled data from 18 randomized controlled trials covering 670 skin wounds across diabetic foot ulcers, leprosy ulcers, burns, skin graft donor sites, episiotomies, sternotomy wounds, bariatric surgery wounds, and hernia repair wounds. The percentage reduction of wound size in the laser therapy group was significantly greater than in the control group (95% CI: 13.93–37.70, p < 0.0001). The rate of complete wound healing was also significantly greater in the laser group (95% CI: 2.32–16.70, p = 0.0003). Pain scores were significantly lower in the treated group (p = 0.02).
This is the first meta-analysis in the literature to evaluate low-level laser therapy across skin wound types in humans, and its results were consistently positive across both primary outcomes.
Diabetic Foot Ulcers
Diabetic foot ulcers have the deepest clinical evidence base for photobiomodulation of any wound type. That depth matters, because diabetic foot ulcers are among the most treatment-resistant wounds in medicine: the lifetime risk of developing one is up to 25% in diabetic patients, and 7% to 20% of those patients will require amputation.
Three independent meta-analyses have reached the same conclusion. Huang et al. (2021) pooled 13 randomized controlled trials involving 413 patients and found that low-level laser therapy significantly increased the complete healing rate (risk ratio 2.10, 95% CI 1.56–2.83, p < 0.00001), significantly reduced ulcer area, and shortened mean healing time. Chen et al. (2025) narrowed in on grade I–II diabetic foot ulcers across 11 studies and 657 participants, confirming that low-level laser therapy is an effective adjuvant that accelerates wound healing. Miranda et al. (2025) ran an umbrella review of all the existing systematic reviews and meta-analyses on photobiomodulation for diabetic ulcers, and found the same consistent positive signal across the published evidence.
The most striking finding comes from a network meta-analysis by Hu et al. (2025) that compared 12 different interventions for diabetic foot ulcers. Low-level laser therapy ranked highest for percentage wound area reduction, with a SUCRA score of 93.9%, meaning it outperformed nearly all other available interventions on this specific outcome in the pooled evidence.
The head-to-head comparison adds further weight. Wadee et al. (2021) randomized 75 patients with chronic diabetic foot ulcers into three groups: low-level laser therapy, hyperbaric oxygen therapy (a well-established but expensive and clinic-bound treatment), and a control group. Both active treatments accelerated healing compared to controls. Critically, low-level laser therapy was more favorable than hyperbaric oxygen in reducing ulcer volume during the first four weeks of treatment. For a therapy that can be given at home without specialized equipment, matching or outperforming an established, more costly clinical intervention is a significant finding.
Burn Wounds
A systematic review and meta-analysis by Pradal et al. (2024) examined photobiomodulation in burn wounds across both clinical and preclinical studies and found positive effects on burn wound healing. A 2025 randomized controlled trial by Yadav et al. studied patients with second-degree burns receiving superpulsed 904 nm laser therapy as an adjunct to standard burn care, and the photobiomodulation group healed faster than the control group.
Surgical and Post-Operative Wounds
Red light therapy's use in surgical wound healing is supported by evidence in both general surgery and oral surgery. Heidari et al. (2017) ran a split-mouth, triple-blind randomized controlled trial on palatal wound healing after gum graft surgery and found that laser-treated sites healed significantly faster, with significantly less pain, than untreated control sites. Bitencourt et al. (2022) confirmed this in a separate triple-blind randomized trial, with the photobiomodulation group healing faster at the surgical donor site.
A systematic review by Gopal et al. (2024) on low-level laser therapy for oral wound healing found that all 14 included studies reported a significant difference between laser and control groups in healing outcomes.
For patients undergoing or recovering from surgery, see our dedicated article on red light therapy after surgery and oral wound healing.
Venous Leg Ulcers and Pressure Injuries
The evidence for venous leg ulcers and pressure injuries is less extensive than for diabetic foot ulcers, with early results pointing in the same positive direction. Bavaresco et al. (2021) randomized patients with venous ulcers to laser therapy plus conventional treatment or conventional treatment alone, and the laser group showed significantly greater wound area reduction. Petz et al. (2019) ran a systematic review of photobiomodulation for pressure ulcer repair in adults and elderly patients and found evidence of benefit in the included studies.
A scoping review by da Silva et al. (2025) examined photobiomodulation for pressure injuries and found positive outcomes across the included studies, while noting the need for larger randomized trials to settle on definitive protocols.
Which Types of Wounds Respond Best, and Where Is the Evidence Still Building?
Strong evidence (multiple meta-analyses): Diabetic foot ulcers have the deepest and most consistent evidence base, with three independent meta-analyses, a network meta-analysis, and a head-to-head trial against hyperbaric oxygen therapy all supporting significant benefit. Skin wounds broadly (including surgical, episiotomy, and burn wounds) are supported by the Taha et al. meta-analysis covering 18 randomized controlled trials.
Strong evidence (systematic reviews and individual RCTs): Oral and dental surgical wounds are supported by multiple systematic reviews and individual triple-blind randomized trials showing accelerated healing and reduced pain. Post-operative wounds at skin graft donor sites and palatal donor sites are supported by multiple randomized trials.
Promising and building: Burn wounds are supported by a systematic review with meta-analysis and individual randomized trials, with consistently positive findings but smaller total patient numbers than the diabetic foot ulcer evidence. Venous leg ulcers and pressure injuries show positive results in individual trials and early systematic reviews, but the total volume of high-quality randomized evidence is still developing.
Where wound severity limits the outcome: Red light therapy is an adjunctive treatment, meaning it works alongside standard wound care, not as a replacement. For wounds driven primarily by uncorrected vascular disease, uncontrolled infection, or severe immunosuppression, the underlying condition must be addressed for any adjunctive therapy to be effective. Photobiomodulation does not substitute for surgical debridement, antibiotics when infection is present, compression therapy for venous disease, or blood sugar control in diabetes. It adds a biological mechanism that standard care cannot provide: direct stimulation of the cellular processes that execute healing.
Conclusion
Wound healing is not a passive process. It is an active biological program that requires energy, organized inflammation, immune cell reprogramming, cell migration, blood vessel growth, collagen production, and oxidative balance, all operating in sequence and in concert. When any of these processes is impaired, whether by diabetes, vascular disease, age, or surgical trauma, the wound stalls.
Red and near-infrared light therapy acts on eight distinct mechanisms that directly support every phase of this program. The clinical evidence, now spanning multiple meta-analyses across wound types, consistently shows that photobiomodulation accelerates healing, improves complete closure rates, and reduces pain. For diabetic foot ulcers, the evidence is among the strongest for any adjunctive wound therapy available, with a network meta-analysis ranking it at the top among 12 compared interventions for wound area reduction.
For anyone living with a wound that has been slow to heal, or anyone recovering from surgery, burns, or an injury that needs reliable tissue repair, the evidence supports red light therapy as a biologically grounded addition to standard wound care. It does not replace good wound management. It supports the cellular processes that good wound management depends on.
